Parenteral Drugs (India) reports consolidated net loss of Rs 24.85 crore in the March 2021 quarter

Sales decline 70.05% to Rs 2.57 crore

Net Loss of Parenteral Drugs (India) reported to Rs 24.85 crore in the quarter ended March 2021 as against net loss of Rs 31.93 crore during the previous quarter ended March 2020. Sales declined 70.05% to Rs 2.57 crore in the quarter ended March 2021 as against Rs 8.58 crore during the previous quarter ended March 2020.

For the full year,net loss reported to Rs 121.71 crore in the year ended March 2021 as against net loss of Rs 114.07 crore during the previous year ended March 2020. Sales declined 61.81% to Rs 12.17 crore in the year ended March 2021 as against Rs 31.87 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales2.578.58 -70 12.1731.87 -62 OPM %131.91-47.67 --96.71-46.06 - PBDT-29.04-32.60 11 -137.15-124.39 -10 PBT-33.36-36.92 10 -154.47-141.74 -9 NP-24.85-31.93 22 -121.71-114.07 -7

Powered by Capital Market - Live News